Literature DB >> 3456605

Primary-structure requirements for inhibition by the heat-stable inhibitor of the cAMP-dependent protein kinase.

J D Scott, M B Glaccum, E H Fischer, E G Krebs.   

Abstract

The amino acid sequence of the heat-stable inhibitor of the cAMP-dependent protein kinase (PKI) was determined recently [Scott, J. D., Fischer, E. H., Takio, K., Demaille, J. G. & Krebs, E. G. (1985) Proc. Natl. Acad. Sci. USA 82, 5732-5736]. An earlier report [Scott, J. D., Fischer, E.H., Demaille, J. G. & Krebs, E. G. (1985) Proc. Natl. Acad. Sci. USA 82, 4379-4383] showed that at least part of the inhibitory domain of PKI is located in a 20-residue segment extending from residue 11 to residue 30: Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-His-Asp-Ile-Leu-Val-Ser- Ser-Ala . In the present study, we further mapped the inhibitory region of PKI by addition or deletion of residues at both ends of this peptide and by substitutions for specific amino acids. The results show that (i) deletion of residues 25-30 did not change inhibitory activity but addition of residues toward the amino terminus increased the inhibitory potency up to 150-fold (Ki 4.8 nM), to a level approaching that of PKI; (ii) replacement of alanine-21 by serine converted the inhibitor into a substrate having a relatively low affinity (Km 280 microM) for the enzyme; (iii) replacement of alanine-21 by phosphoserine or alpha-aminobutyric acid decreased inhibitory activity by a factor of 120 and 20, respectively; (iv) replacement of serine-13 had essentially no effect, whereas substitution of threonine-16 decreased inhibitory activity. The greatest decreases of inhibitory potency occurred with replacements of the arginines in positions 18 and 19.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456605      PMCID: PMC323133          DOI: 10.1073/pnas.83.6.1613

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  The protein inhibitor of adenosine 3',5'-monophosphate-dependent protein kinases. The NH2-terminal portion of the peptide chain contains the inhibitory site.

Authors:  J G Demaille; C Ferraz; E H Fischer
Journal:  Biochim Biophys Acta       Date:  1979-08-22

2.  Non-dependence on native structure of pig liver pyruvate kinase when used as a substrate for cyclic 3',5'-AMP-stimulated protein kinase.

Authors:  E Humble; L Berglund; V Titanji; O Ljungström; B Edlund; O Zetterqvist; L Engström
Journal:  Biochem Biophys Res Commun       Date:  1975-09-16       Impact factor: 3.575

3.  Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase.

Authors:  B E Kemp; D J Graves; E Benjamini; E G Krebs
Journal:  J Biol Chem       Date:  1977-07-25       Impact factor: 5.157

4.  Isolation and properties of the rabbit skeletal muscle protein inhibitor of adenosine 3',5'-monophosphate dependent protein kinases.

Authors:  J G Demaille; K A Peters; E H Fischer
Journal:  Biochemistry       Date:  1977-07-12       Impact factor: 3.162

Review 5.  Phosphorylation-dephosphorylation of enzymes.

Authors:  E G Krebs; J A Beavo
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

6.  Inhibition of cyclic AMP-dependent protein kinase by analogues of a synthetic peptide substrate.

Authors:  J R Feramisco; E G Krebs
Journal:  J Biol Chem       Date:  1978-12-25       Impact factor: 5.157

7.  Characterization of the interaction of a protein inhibitor with adenosine 3',5'-monophosphate-dependent protein kinases. II. Mechanism of action with the holoenzyme.

Authors:  C D Ashby; D A Walsh
Journal:  J Biol Chem       Date:  1973-02-25       Impact factor: 5.157

8.  Krebs EG: Purification and characterization of a protein inhibitor of adenosine 3',5'-monophosphate-dependent protein kinases.

Authors:  D A Walsh; C D Ashby; C Gonzalez; D Calkins; E H Fischer
Journal:  J Biol Chem       Date:  1971-04-10       Impact factor: 5.157

9.  A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase.

Authors:  H C Cheng; B E Kemp; R B Pearson; A J Smith; L Misconi; S M Van Patten; D A Walsh
Journal:  J Biol Chem       Date:  1986-01-25       Impact factor: 5.157

10.  Synthetic hexapeptide substrates and inhibitors of 3':5'-cyclic AMP-dependent protein kinase.

Authors:  B E Kemp; E Benjamini; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

View more
  50 in total

1.  Retroviral inhibition of cAMP-dependent protein kinase inhibits myelination but not Schwann cell mitosis stimulated by interaction with neurons.

Authors:  D G Howe; K D McCarthy
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

2.  Cloning and mapping of human PKIB and PKIG, and comparison of tissue expression patterns of three members of the protein kinase inhibitor family, including PKIA.

Authors:  L Zheng; L Yu; Q Tu; M Zhang; H He; W Chen; J Gao; J Yu; Q Wu; S Zhao
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

3.  Bioinformatic design of A-kinase anchoring protein-in silico: a potent and selective peptide antagonist of type II protein kinase A anchoring.

Authors:  Neal M Alto; Scott H Soderling; Naoto Hoshi; Lorene K Langeberg; Rosa Fayos; Patricia A Jennings; John D Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

4.  An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria.

Authors:  Christopher K Means; Birgitte Lygren; Lorene K Langeberg; Ankur Jain; Rose E Dixon; Amanda L Vega; Matthew G Gold; Susanna Petrosyan; Susan S Taylor; Anne N Murphy; Taekjip Ha; Luis F Santana; Kjetil Tasken; John D Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

5.  Dependence of urokinase-type-plasminogen-activator induction on cyclic AMP-dependent protein kinase activation in LLC-PK1 cells.

Authors:  D A Jans; T J Resink; B A Hemmings
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

6.  Microinjection of synthetic protein kinase inhibitor into single barnacle muscle fibers before and after cyclic AMP.

Authors:  E E Bittar; J Nwoga
Journal:  Experientia       Date:  1987-09-15

7.  Mutant regulatory subunit of 3',5'-cAMP-dependent protein kinase of yeast Saccharomyces cerevisiae.

Authors:  S Yamano; K Tanaka; K Matsumoto; A Toh-e
Journal:  Mol Gen Genet       Date:  1987-12

8.  Comparative rates of desensitization of beta-adrenergic receptors by the beta-adrenergic receptor kinase and the cyclic AMP-dependent protein kinase.

Authors:  N S Roth; P T Campbell; M G Caron; R J Lefkowitz; M J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

9.  CRF facilitates calcium release from intracellular stores in midbrain dopamine neurons.

Authors:  Arthur C Riegel; John T Williams
Journal:  Neuron       Date:  2008-02-28       Impact factor: 17.173

Review 10.  Evolution of a dynamic molecular switch.

Authors:  Susan S Taylor; Hiruy S Meharena; Alexandr P Kornev
Journal:  IUBMB Life       Date:  2019-05-06       Impact factor: 3.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.